Use: Labeled indications
- INDICATIONS AND USAGE Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by Candida albicans .
Full indications and usage US FDA label
INDICATIONS AND USAGE Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by Candida albicans.
Contraindications
CONTRAINDICATIONS Nystatin is contraindicated in patients with a history of hypersensitivity to nystatin or any of the suspension components.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION Infants: 2 mL (200,000 units) four times daily (1 mL in each side of mouth). Pediatric patients and adults: 4 to 6 mL (400,000 to 600,000 units) four times daily (one-half of dose in each side of mouth). NOTE: Limited clinical studies in neonates, including premature and low-birth weight neonates, indicate that 1 mL (100,000 units) four times daily is effective.
Local treatment should be continued at least 48 hours after perioral symptoms have disappeared and/or cultures returned to normal. It is recommended that the drug be retained in the mouth as long as possible before swallowing.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Oral suspension: 100,000 IU/mL, 100,000 units/mL
- Suspension for oral drops: 100,000 units/mL
- Ointment ointment: 100,000 units
- Suspension: 100,000 units/mL
Registered products in the Philippines
29 products registered with the Food and Drug Administration (FDA) Philippines list Nystatin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products29
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AdnystNystatin | 100,000 units/mL Oral SuspensionAmber Glass Bottle x 12 mL | Rx | Somatec Pharmaceuticals Ltd.Bangladesh | Advance Pharma Distribution Corp.Importer: Bridgemark Marketing | DRP-3559-05 | Nov 23, 2027 | |
AfunginalNystatin | 100,000 I.U./mL Oral SuspensionAmber Glass Bottle x 12 mL and 30 mL w/ Calibrated Dropper (Box of 1's) | Rx | The ACME Laboratories LimitedBangladesh | Remed Pharmaceuticals, Inc.Importer: Euro Generics International Phils., Inc. | DRP-587 | Aug 29, 2028 | |
BionystNystatin | 100,000 units/mL Oral SuspensionAmber Glass Bottle x 12 mL | Rx | Somatec Pharmaceuticals Ltd.Bangladesh | All-Bio Pharma, Inc.Importer: Bridgemark Marketing | DRP-3559-01 | Nov 23, 2027 | |
EmnystatNystatin | 100,000 IU/mL Oral Suspension (Drops)12 mL Net Content in 15 mL Capacity Amber Glass Bottle with Plastic Dropper (Box of 1's) | Rx | Norris Medicines LimitedIndia | Emhealthcare Pharma Traders Inc.Importer: Medethix, Inc.Trader: Aumgen Pharma LLP. | DRP-5479-01 | Aug 26, 2029 | |
FungystNystatin | 100,000 IU/mL Oral SuspensionAmber glass boston brown bottle x 30 mL (Box of 1's); Amber glass boston brown bottle x 12 mL in 15 mL capacity bottle (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-13438 | Nov 16, 2028 | |
GozenystNystatin | 100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 mL with Plastic Dropper (Box of 1's) | Rx | S Kant Healthcare Ltd.India | Applied Pharmaceutical Distribution IncImporter: Medinova Pharmaceutical Inc. | DRP-15585-01 | Aug 6, 2029 | |
HiztatinNystatin | 100,000 Units/mL Oral Suspension30 mL Amber glass bottle with aluminum PP cap and plastic dropper (Box of 1's) | Rx | Kwality Pharmaceuticals Ltd.India | Pharmacia HizkiahImporter: Pharma-Surrey International, Inc. | DRP-7142-02 | Apr 3, 2027 | |
MedinystNystatin | 100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 mL with Plastic Dropper (Box of 1's) | Rx | S Kant Healthcare Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-15585-03 | Aug 6, 2029 | |
MyconilNystatin | 100,000 IU / mL Oral Suspension (Oral Drops)Boston Round Amber Bottle with pilfer proof aluminum cap (printed Amson logo) and medicine plastic dropper x 30 mL (Box of 1's) | Rx | Amson Vaccines & Pharma (Pvt.) Ltd.Pakistan | SAHAR INTERNSahar International Trading, Inc.ATIONAL TRADING, INC.Importer: Sahar International Trading, Inc. | DRP-7275 | Dec 11, 2029 | |
MystinNystatin | 100,000 Units/mL Oral SuspensionAmber Bottle x 12 mL in 15 mL and 30 mL with medicine dropper (Box of 1's) | Rx | Scheele Laboratories Phils., Inc.Philippines | — | DRP-4894 | Nov 6, 2028 | |
NovastatinNystatin | 100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 mL with Plastic Dropper (Box of 1's) | Rx | S Kant Healthcare Ltd.India | Medinova Pharmaceutical Inc.. | DRP-15585 | Aug 6, 2029 | |
NysaphNystatin | Suspension for Oral Drops 100,000 units/mL12 mL Amber Bottle with White Screw Pilfer Proof Cap; 15 mL Amber Bottle with White Screw Pilfer Proof Cap; 30 mL Amber Bottle with White Screw Pilfer Proof Cap | Rx | Sapphire Lifesciences Pvt. LtdIndia | Nelpa Lifesciences, Inc. | DRP-5138 | Feb 13, 2029 | |
NystNystatin | 100,000 units/mL Oral SuspensionAmber Glass Bottle x 12mL | Rx | Somatec Pharmaceuticals Ltd.Bangladesh | Bridgemark Marketing | DRP-3559 | Nov 23, 2027 | |
NystajingNystatin | 100,000 Units / mL Oral SuspensionAmber Bottle x 30 mL with medicine dropper (Box of 1's) | Rx | Scheele Laboratories Phils., Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-4894-01 | Nov 6, 2028 | |
NystarexNystatin | 100,000 units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc. | DRP-6556-02 | Mar 7, 2031 | |
NystcareNystatin | 100,000 Units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc. | DRP-6556-05 | Mar 7, 2031 | |
NystorNystatin | 100,000 units/Ointment OintmentAluminum collapsible tube with white HPDE cap x 15 g and 30 g (Box of 1's) | Rx | TORRENT PHARMACEUTICALS LTD.India | Torrent Pharma Philippines, Inc. | DR-XY48888 | Oct 2, 2028 | |
NystrinNystatin | 100,000 units/mL Suspension (Oral Drops)Amber Bottle x 30 mL with Golden Yellow Aluminum Screw Cap with Dropper (Box of 1's) | Rx | Harmann Pharmaceutical Labs. (Pvt.) Ltd.Pakistan | Raquel-Abbas Pharmaceuticals & General Merchandise. | DRP-5556 | Sep 30, 2029 | |
NyszacNystatin | 100,000 IU/mL Oral Suspension (Drops)12 mL Net Content in 15 mL Capacity Amber Glass Bottle with Plastic Dropper (Box of 1's) | Rx | Norris Medicines LimitedIndia | Medethix, Inc.Trader: Alvita Pharma Pvt. Ltd. | DRP-5479 | Aug 26, 2029 | |
NytasethNystatin | 100,000 units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Eliset Pharmaceutical, Inc.Importer: Accesspoint International Trading Inc. | DRP-6556-3 | Mar 7, 2031 | |
OraseaNystatin | 100,000 Units/mL Oral Suspension30 mL Amber Glass Bottle with Aluminum PP Cap and Plastic Dropper (Box of 1's) | Rx | Kwality Pharmaceuticals Ltd.India | Seapharma International, Inc.Importer: Pharma-Surrey International, Inc. | DRP-7142-03 | Apr 3, 2027 | |
OrastatNystatin | 100,000 Units/mL Oral Suspension30 mL Amber glass bottle with aluminum PP cap and plastic dropper (Box of 1's) | Rx | Kwality Pharmaceuticals Ltd.India | Pharma-Surrey International, Inc. | DRP-7142 | Apr 3, 2027 | |
OrastinNystatin | 100,000 I.U./mL Oral SuspensionAmber Glass Bottle x 12 mL w/ Calibrated Dropper (Box of 1's) | Rx | The ACME Laboratories LimitedBangladesh | Euro Generics International Phils., Inc. | DRP-587-03 | Aug 29, 2028 | |
RetanystNystatin | 100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 ml with Plastic Dropper (Box of 1's) | Rx | S Kant Healthcare Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-15585-02 | Aug 6, 2029 | |
RextatinNystatin | 100,000 Units/mL Oral Suspension30 mL Amber glass bottle with aluminum PP cap and plastic dropper (Box of 1's) | Rx | Kwality Pharmaceuticals LtdIndia | Rexmed Pharmaceutical SalesImporter: Pharma-Surrey International, Inc. | DRP-7142-04 | Apr 3, 2027 | |
RynystatinNystatin | 100,000 units/mL Suspension for Oral Drops12 mL Amber Bottle with White Screw Pilfer Proof Cap (Box of 1’s); 15 mL Amber Bottle with White Screw Pilfer Proof Cap (Box of 1’s); 30 mL Amber Bottle with White Screw Pilfer Proof Cap (Box of 1’s) | Rx | Enicar Pharmaceuticals Pvt. Ltd.India | Rinon Care Pharma, Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-5138-02 | Feb 13, 2029 | |
TeranystNystatin | 100,000 IU/mL Oral SuspensionAmber glass boston brown bottle x 30 mL (Box of 1's); Amber glass boston brown bottle x 12 mL in 15 mL capacity (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Terramedic, Inc. | DRP-13438-01 | Nov 16, 2028 | |
Z-NystNystatin | 100,000 units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-6556 | Mar 7, 2031 | |
ZystinNystatin | 100,000 units/mL Oral SuspensionAmber Glass Bottle x 12 mL | Rx | Somatec Pharmaceuticals Ltd.Bangladesh | JZ PharmazoneImporter: Bridgemark Marketing | DRP-3559-03 | Nov 23, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
PRECAUTIONS General Discontinue treatment with nystatin if sensitization or irritation is reported during use. Nystatin is not effective in the treatment of systemic mycoses since it is not significantly absorbed from the gastrointestinal tract. Information for the Patient Patient should be advised to retain nystatin in the mouth as long as possible and to continue its use for at least 2 days after symptoms have subsided.
There should be no interruption or discontinuation of the medication until the prescribed course of treatment is completed, even though symptomatic relief may occur within a few days. If symptoms of local irritation develop, the physician should be notified immediately. Laboratory Tests If there is a lack of therapeutic response, appropriate microbiological studies (e.g., KOH smears and/or cultures) should be repeated to confirm the diagnosis of candidiasis and rule out other pathogens before instituting another course of therapy.
Carcinogenesis, Mutagenesis, Impairment of Fertility No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. In mice exposed to nystatin 50 mg/kg by injection, an increased incidence of chromosomal aberrations, consisting primarily of chromatid breaks, was observed in bone marrow cells.
However, there have been no studies to determine the mutagenicity of orally-administered nystatin or its effects on fertility in males or females. Pregnancy Teratogenic effects Teratogenicity studies have not been conducted with nystatin. It is also not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
Nystatin should be given to a pregnant woman only if clearly needed. Nonteratogenic effects In one rat reproductive study, nystatin was administered orally to pregnant rats in single doses of 100, 500, or 3000 mg/kg on the ninth day of gestation, or as multiple doses of 500 mg/kg/day on gestation days 1-20, 1-4, 7-10, 11-14, or 15-18.
It was found that nystatin had a slight abortive effect when used during the whole period of pregnancy. No abnormalities were seen in surviving fetuses. Although no adverse effects or complications have been attributed to the use of intra-vaginal nystatin in neonates born to women treated during pregnancy, no similar studies evaluating complications of oral nystatin have been conducted.
Nursing Mothers It is not known whether nystatin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when nystatin is administered to a nursing woman. Pediatric Use See DOSAGE AND ADMINISTRATION section for pediatric dosing recommendations.
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Gastrointestinal symptoms including diarrhea, gastrointestinal distress, nausea, vomiting and burning of the mouth have been reported. Hypersensitivity reactions including rash, pruritus, and anaphylactoid reaction have also been reported.
Pharmacokinetics
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Nystatin acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is absorbed very sparingly following oral administration, with no detectable blood levels when given in the recommended doses.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Nystatin 100,000 units/mL, 30 mL Suspension | ₱50.00–₱268.00Reference ₱155.00 | per unit | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Nystatin |
| PNF listing | Oral: 100,000 units/mL suspension, 30 mL |
| PNF listing | Vaginal: 100,000 units per tablet |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Nystatin · Chartwell Governmental & Specialty RX, LLC [US FDA-approved label, version 1, November 12, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88a0a22e-8d6b-42aa-b225-2d57fb5b3a97
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .